This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Bird Flu Sends China's Drug Stocks Flying

BEIJING ( TheStreet) -- Stock advisers are telling Chinese investors to take a gander at drug and medical supply companies now that a deadly strain of bird flu is spreading on the eve of the country's annual Spring Festival travel blitz.

Buy signals have been flashing this week for vaccine manufacturer Hualan Biological, virus test kit specialist Da An Gene and drug maker Shanghai Kai Bao Pharmaceutical.

Analysts have also recommended shares in makers of traditional Chinese medicines designed to fight viruses and prevent disease. Recommended stocks included Yiling Pharmaceutical and Guangzhou Pharmaceutical.

Hualan has been working on an H7N9 vaccine since last year, when it got a green light from the World Health Organization to develop the product. A government drug regulator for China's Henan Province registered the vaccine January 3, clearing the way for clinical trials.

Meanwhile, the traditional Chinese medicine supplier Lianghua Qingwen, which is not listed, has been stoking public interest in bird flu drugs by advertising a product it makes from rare Tibetan plants as an immune system-booster that prevents H7N9.

On the Shanghai Stock Exchange, Hualan saw its stock value slip 0.1% Thursday in heavy trading to close at 29.43 yuan. Guangzhou's shares fell 0.3% to finish at 26.33 yuan.

On the Shenzhen exchange Thursday, shares in Kai Bao jumped 3.7% to close at 17.48 yuan, Da An stock rose 2.8% to finish the day at 15.66 yuan, and Yiling gained 2.1% to 34.93 yuan.

Since Jan. 1, health authorities say more than 40 people in Shanghai and four provinces have been confirmed to have been infected with the H7N9 strain of bird flu, which officials say is transmitted from live birds to people but not from human to human.

At least two people have died so far this month, coincidentally on the same day in Shanghai, according to China's National Health and Family Planning Commission. A 31-year-old man and a 77-year-old woman were admitted to separate hospitals Jan. 17 and died the next day.

The outbreak comes as hundreds of millions of migrant workers, university students and others prepare to travel to their hometowns for the traditional Spring Festival holiday period, which begins with the Chinese New Year celebration Jan, 31. Health officials fear travelers carrying live poultry could spread H7N9 infections.

-- Written by Eric Johnson in Beijing

At the time of publication the author had no position in the companies mentioned.

 

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $126.41 -1.66%
FB $81.21 0.39%
GOOG $575.33 0.34%
TSLA $200.63 -0.89%
YHOO $44.16 0.39%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs